FindTrial
Sign In

The relationship between the expression of renal tissue EXTI/2 antigens and renal function progression with Chinese Zhuang membrane nephropathy :a cohort study

The relationship between the expression of renal tissue EXTI/2antigens and renal function progression with Chinese Zhuang membrane nephropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054567
Enrollment
Unknown
Registered
2021-12-20
Start date
2021-12-06
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

membrane nephropathy

Interventions

EXT1/EXT2 (positive vs. negative):None

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with membranous nephropathy diagnosed by renal biopsy; 2. Aged >= 14 years; 3. Biopsy of >=8 glomeruli; 4. The expected survival time is more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Patients with baseline eGFR<30ml/min/1.73m2; 2. The follow-up time is less than 12 months; 3. Other conditions deemed inappropriate by other clinicians to participate in this study.

Design outcomes

Primary

MeasureTime frame
Renal biopsy target antigen EXT1/2 expression;—

Countries

China

Contacts

Public ContactWan Qijun

Shenzhen Second People's Hospital

yiyuan@sina.com+86 13537857368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026